The PurpleLab^® Resource Center

Pharmaceutical brands and media platforms, including connected TV (CTV), can activate HIPAA-compliant audiences built on real-world clinical and claims data through a new collaboration between PurpleLab® and Experian. Targeting de-identified audiences is essential for engaging the right patients at pivotal moments in their health journey—maximizing ROI while safeguarding privacy and improving outcomes. Overall, prescription drugmakers…

Healthcare advertising works best when it’s both precise and efficient. That’s why we’re excited to announce a direct partnership with DeepIntent, bringing our high-quality audiences into the DeepIntent Audience Marketplace. This integration gives marketers faster, easier access to PurpleLab’s audiences, delivering better performance, greater scale, and sharper precision within a seamless workflow. For advertisers, that…

Biomarker testing guides selection of targeted therapies in non–small cell lung cancer (NSCLC). Despite its clinical importance, the extent of provider variation in biomarker testing practices and its correlation with patient outcomes has not been thoroughly explored.